ESMO Launches Peer-Reviewed Journal Focused on AI in Oncology
The European Society for Medical Oncology has introduced a peer-reviewed journal dedicated to artificial intelligence applications in cancer research and clinical practice, marking a key development in oncology.

AI News in the United States
Part 1 of 3
Table of Contents
On November 16, 2026, the European Society for Medical Oncology (ESMO) announced the launch of a new peer-reviewed journal titled “ESMO Artificial Intelligence and Oncology.” This publication focuses on the diverse applications of artificial intelligence across cancer research and clinical care, providing a platform for original research, reviews, and educational content addressing AI’s impact on oncology diagnostics, treatment, and healthcare workflows.
Led by Editor-in-Chief Prof. Dr. med. Jakob Nikolas Kather, the journal emphasizes rigorous validation and practical guidance for clinicians and researchers. The launch coincided with the opening of the second ESMO AI and Digital Oncology Congress in Lugano, Switzerland, highlighting the society’s commitment to advancing AI innovations responsibly in cancer medicine.
The journal aims to promote multidisciplinary collaboration and ensure AI tools meet clinical standards for patient care by publishing studies on pathology, molecular profiling, diagnostic imaging, clinical decision support, drug development, healthcare workflows, regulatory issues, medical education, and health economics.
This initiative reflects the growing integration of AI technologies into oncology, supporting the safe and effective adoption of AI in cancer medicine.


